Juan Camilo Arjona Ferreira - Aug 11, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Stock symbol
OGN
Transactions as of
Aug 11, 2024
Transactions value $
-$80,419
Form type
4
Date filed
8/12/2024, 05:18 PM
Previous filing
Apr 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +11.5K +86284.64% $0.00 11.5K Aug 11, 2024 Direct
transaction OGN Common Stock Tax liability -$80.4K -3.99K -34.61% $20.15 7.54K Aug 11, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -11.5K -33.33% $0.00 23K Aug 11, 2024 Common Stock 11.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Organon common stock.
F2 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments of 11,519 shares on each of August 11, 2024; August 11, 2025; and August 11, 2026.